{"product_id":"9789401040143","title":"Developments in Cardiovascular Medicine: Viability, Perfusion, Receptors and Cardiomyopathy","description":"\u003ch1\u003eDevelopments in Cardiovascular Medicine: Viability, Perfusion, Receptors and Cardiomyopathy\u003c\/h1\u003e \u003ch2\u003evan der Wall, Ernst E.; Blanksma, P.K.; Niemeyer, M.G.; Paans, A.M.\u003c\/h2\u003e \u003cp\u003eMyocardial viability has become one of the most important  issues in clinical cardiology. In particular, absence or presence of  viability may be decisive in patient management, and the decision to  perform angioplasty (PTCA) or bypass surgery (CABG) is frequently  based on the accurate assessment of viability. Although  echocardiography and conventional nuclear medicine techniques may  provide valuable information on viability, positron emission  tomography (PET) is currently considered to be the gold standard for  the assessment of myocardial viability. The simultaneous evaluation of  myocardial metabolism and perfusion allows precise delineation and  accurate quantification of residual myocardial viability in affected  regions. In addition, accurate quantification of myocardial perfusion  alone may provide insight into the basic mechanisms of syndrome X and  may assist in the appropriate clarification of this clinically  complicated, but frequently occurring phenomenon. \u003cbr\u003e  Besides that, cardiac PET may deepen our insight into metabolism and  perfusion of cardiac muscle disease, particularly in hypertrophic  cardiomyopathy. Furthermore, receptor imaging studies with PET will  become important as the study of cardiac neurohumoral regulation in  heart failure has gained in interest. \u003cbr\u003e  \u003cem\u003eCardiac Positron Emission Tomography: Viability, Perfusion,\u003c\/em\u003e  \u003cem\u003eReceptors and Cardiomyopathy\u003c\/em\u003e describes the most recent  developments in cardiac PET as these are related to myocardial  viability and myocardial perfusion studies of syndrome X. The value of  PET for receptor imaging and cardiac muscle disease is also discussed.  \u003cbr\u003e  For cardiologists, nuclear medicine physicians, radiochemists,  physiologists, technicians and basic researchers interested in  understanding the most recent achievements in cardiovascular PET.  \u003cbr\u003e\u003c\/p\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Springer\u003c\/p\u003e \u003cp\u003ePublication Date: 2012-11-13\u003c\/p\u003e \u003cp\u003eFormat: Paperback\u003c\/p\u003e \u003cp\u003eISBN-13: 9789401040143\u003c\/p\u003e \u003cp\u003eDOI: 10.1007\/978-94-011-0023-6\u003c\/p\u003e \u003cp\u003eDimensions: 240cm x160cm\u003c\/p\u003e \u003cp\u003ePages: 256\u003c\/p\u003e ","brand":"Springer Netherlands","offers":[{"title":"Default Title","offer_id":47378659672204,"sku":"9789401040143","price":49.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9789401040143.jpg?v=1775710387","url":"https:\/\/fh90cf-fv.myshopify.com\/products\/9789401040143","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}